Editorial: subcutaneous CT-P13 in Crohn's disease and ulcerative colitis-small change, big consequences. Authors' reply

Aliment Pharmacol Ther. 2022 Jan;55(2):253-254. doi: 10.1111/apt.16724.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Colitis, Ulcerative*
  • Crohn Disease* / diagnostic imaging
  • Humans
  • Infliximab

Substances

  • Antibodies, Monoclonal
  • CT-P13
  • Infliximab